Chemicals giant Bayer announced Monday it will produce from 2022 a coronavirus vaccine that fellow German pharmaceuticals company CureVac is developing. “I am happy to tell you that we have the necessary capacities to produce CureVac’s mRNA-based vaccine,” Bayer’s head of pharmaceuticals Stefan Oelrich told reporters. He added that the company aimed to produce 160 […]